众生药业(002317.SZ)：前三季净利润2.5亿元 同比增长68.4%

Core Viewpoint - Zhongsheng Pharmaceutical (002317.SZ) reported a slight decline in revenue for the first three quarters of the year, while net profit showed significant growth, indicating a potential resilience in profitability despite revenue challenges [1] Financial Performance - The company's operating revenue for the first three quarters was 1.889 billion yuan, a year-on-year decrease of 1.01% [1] - The net profit attributable to shareholders of the listed company reached 250 million yuan, reflecting a year-on-year increase of 68.4% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 246 million yuan, which represents a year-on-year growth of 30.36% [1]